P. Roma et al., INVIVO METABOLISM OF A MUTANT FORM OF APOLIPOPROTEIN A-I, APO A-I(MILANO), ASSOCIATED WITH FAMILIAL HYPOALPHALIPOPROTEINEMIA, The Journal of clinical investigation, 91(4), 1993, pp. 1445-1452
Apo A-I(Milano) is a mutant form of apo A-I in which cysteine is subst
ituted for arginine at amino acid 173. Subjects with apo A-I(Milano) a
re characterized by having low levels of plasma HDL cholesterol and ap
o A-I. To determine the kinetic etiology of the decreased plasma level
s of the apo A-I in these individuals, normal and mutant apo A-I were
isolated, radiolabeled with either I-125 or I-131, and both types of a
po A-I were simultaneously injected into two normal control subjects a
nd two subjects heterozygous for apo A-I(Milano). In the normal subjec
ts, apo A-I(Milano) was catabolized more rapidly than the normal apo A
-I (mean residence times of 5.11 d for normal apo A-I vs. 3.91 d for a
po A-I(Milano)), clearly establishing that apo A-I(Milano) is kinetica
lly abnormal and that it has a shortened residence time in plasma. In
the two apo A-I(Milano) subjects, both types of apo A-I were cataboliz
ed more rapidly than normal (residence times ranging from 2.63 to 3.70
d) with normal total apo A-I production rates (mean of 10.3 vs. 10.4
mg/kg per d in the normal subjects). Therefore, in the subjects with a
po A-I(Milano), the decreased apo A-I levels are caused by rapid catab
olism of apo A-I and not to a decreased production rate, and the abnor
mal apo A-I(Milano) leads to the rapid catabolism of both the normal a
nd mutant forms of apo A-I in the affected subjects.